Roles of the Skp2/p27 axis in the progression of chronic nephropathy

Sayuri Suzuki1, Naro Ohashi, Masatoshi Kitagawa

  • 1Department of Molecular Biology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.

Insights

S-phase kinase-associated protein 2 (Skp2) promotes kidney damage by degrading p27. Inhibiting Skp2 or preserving p27 levels may protect against progressive nephropathy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Nephrology

Background:

  • S-phase kinase-associated protein 2 (Skp2) is an F-box protein crucial for the ubiquitin-dependent degradation of cell cycle regulators.
  • Skp2 targets p27, a cyclin-dependent kinase inhibitor, influencing cell cycle progression and tubular epithelial cell proliferation.
  • Tubular epithelial cell proliferation is a hallmark of early nephropathy, with p27 levels correlating with renal injury progression.

Purpose of the Study:

  • To investigate the role of the Skp2/p27 axis in the pathogenesis of progressive nephropathy.
  • To elucidate the functional significance of Skp2-mediated p27 degradation in renal damage.

Main Methods:

  • Utilized a mouse model of unilateral ureteral obstruction (UUO) to induce renal injury.
  • Compared renal damage and p27 accumulation in wild-type, Skp2 knockout (Skp2(-/-)), and double knockout (Skp2(-/-)/p27(-/-)) mice.
  • Assessed the impact of Skp2 and p27 deficiency on tubular epithelial cell proliferation and renal pathology post-UUO.

Main Results:

  • Unilateral ureteral obstruction (UUO)-induced renal damage was ameliorated in Skp2(-/-) mice, correlating with increased p27 accumulation in tubular epithelial cells.
  • The protective effect observed in Skp2(-/-) mice was abolished in Skp2(-/-)/p27(-/-) mice, indicating p27's critical role in this amelioration.
  • These findings highlight Skp2-mediated p27 reduction as a pathogenic mechanism in progressive nephropathy.

Conclusions:

  • The Skp2/p27 axis plays a significant role in the progression of chronic nephropathy.
  • Targeting Skp2 or modulating p27 levels presents a potential therapeutic strategy for mitigating renal injury.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...